Systematic follow-up and case management of the abnormal newborn screen can improve acceptance of genetic counseling for sickle cell or other hemoglobinopathy trait.
OBJECTIVE
Sickle cell or other hemoglobinopathy trait detected on the newborn screen provides an opportunity for genetic counseling of families at risk of having a child with a major hemoglobinopathy. However, follow-up of hemoglobinopathy trait is often fragmented and acceptance of counseling is low. We describe the results of systematic follow-up and case management of abnormal newborn screen and the effect on acceptance of counseling.


METHODS
From July 1997 to June 2002, families of a newborn with hemoglobinopathy trait were notified by mail. In April 2003, an intensive trait follow-up protocol including letters, telephone calls, educational videos, and genetic counseling was implemented. Demographic information and follow-up activity were documented and tracked using an electronic database.


RESULTS
From July 1997 to June 2002, 3095 families were notified by letter of a newborn with hemoglobinopathy trait and were offered genetic counseling. Of these, 165 (5.3%) received counseling by telephone and 60 (2%) underwent extended family testing. From April to December 2003, 694 families with a newborn with hemoglobinopathy trait were notified by mail. Of these, 362 (52%) families were reached by telephone. Of those contacted by telephone, 92% received genetic counseling via telephone, 57% were interested in family testing, and 12% scheduled an appointment. Additionally, 27% of families were mailed an educational video. Among those declining extended family testing, 26% preferred to consult their pediatrician.


CONCLUSIONS
Systematic follow-up and case management of abnormal newborn screen can improve the acceptance of genetic counseling.
Kladny
Beth
B
Department of Genetics Magee Women's Hospital, Pittsburgh, Pennsylvania, USA.
Gettig
Elizabeth A
EA
Krishnamurti
Lakshmanan
L
D019090:Case Management; D003710:Demography; D005260:Female; D005500:Follow-Up Studies; D005817:Genetic Counseling; D006453:Hemoglobinopathies / Q000175:diagnosis* / Q000235:genetics*; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D015997:Neonatal Screening; D010349:Patient Compliance; D010372:Pediatrics; D012017:Referral and Consultation; D012307:Risk Factors